These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 25246303
1. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene. D'Arcy C, Kanellakis V, Forbes R, Wilding B, McGrath M, Howell K, Ryan M, McLean C. J Child Neurol; 2015 Aug; 30(9):1211-7. PubMed ID: 25246303 [Abstract] [Full Text] [Related]
2. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report. Giucă A, Mitu C, Popescu BO, Bastian AE, Capşa R, Mursă A, Rădoi V, Popescu BA, Jurcuţ R. BMC Med Genet; 2020 Sep 29; 21(1):188. PubMed ID: 32993534 [Abstract] [Full Text] [Related]
3. FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy. Chen T, Lu X, Shi Q, Guo J, Wang H, Wang Q, Yin X, Zhang Y, Pu C, Zhou D. Neuromuscul Disord; 2020 Feb 29; 30(2):165-172. PubMed ID: 32001145 [Abstract] [Full Text] [Related]
6. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation. Wilding BR, McGrath MJ, Bonne G, Mitchell CA. J Cell Sci; 2014 May 15; 127(Pt 10):2269-81. PubMed ID: 24634512 [Abstract] [Full Text] [Related]
8. Myofibrillar myopathy caused by a novel FHL1 mutation presenting a mild myopathy with ankle contracture. Park YE, Kim DS, Shin JH. Clin Neurol Neurosurg; 2019 May 15; 180():48-51. PubMed ID: 30928807 [Abstract] [Full Text] [Related]
9. Fhl1 W122S causes loss of protein function and late-onset mild myopathy. Emmanuele V, Kubota A, Garcia-Diaz B, Garone C, Akman HO, Sánchez-Gutiérrez D, Escudero LM, Kariya S, Homma S, Tanji K, Quinzii CM, Hirano M. Hum Mol Genet; 2015 Feb 01; 24(3):714-26. PubMed ID: 25274776 [Abstract] [Full Text] [Related]
11. Novel FHL1 mutation in a family with reducing body myopathy. Schreckenbach T, Henn W, Kress W, Roos A, Maschke M, Feiden W, Dillmann U, Schulz JB, Weis J, Claeys KG. Muscle Nerve; 2013 Jan 01; 47(1):127-34. PubMed ID: 23169582 [Abstract] [Full Text] [Related]
12. Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene. Binder JS, Weidemann F, Schoser B, Niemann M, Machann W, Beer M, Plank G, Schmidt A, Bisping E, Poparic I, Lafer I, Stojakovic T, Quasthoff S, Vincent JB, Rienmueller R, Speicher MR, Berghold A, Pieske B, Windpassinger C. Circ Cardiovasc Genet; 2012 Oct 01; 5(5):490-502. PubMed ID: 22923418 [Abstract] [Full Text] [Related]
16. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B, Farra N, Petek E, Schwarzbraun T, Ofner L, Löscher WN, Wagner K, Lochmüller H, Vincent JB, Quasthoff S. Am J Hum Genet; 2008 Jan 01; 82(1):88-99. PubMed ID: 18179888 [Abstract] [Full Text] [Related]
17. Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation. Knoblauch H, Geier C, Adams S, Budde B, Rudolph A, Zacharias U, Schulz-Menger J, Spuler A, Yaou RB, Nürnberg P, Voit T, Bonne G, Spuler S. Ann Neurol; 2010 Jan 01; 67(1):136-40. PubMed ID: 20186852 [Abstract] [Full Text] [Related]
19. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Cowling BS, Cottle DL, Wilding BR, D'Arcy CE, Mitchell CA, McGrath MJ. Neuromuscul Disord; 2011 Apr 01; 21(4):237-51. PubMed ID: 21310615 [Abstract] [Full Text] [Related]